In this context and given the difficulty in morphologically distinguishing some LCNEC from grade 3 NET, we can speculate that classification of grade 3 NEN based on p53/RB alteration rather than morphology may be clinically relevant. The gene discussed is TP53; the disease is large cell neuroendocrine carcinoma.